Comparison of treatment patterns, resource utilization, and cost of care in patients with metastatic pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine or FOLFIRINOX

Cost-effectiveness of FOLFIRINOX for first-line treatment of metastatic pancreatic cancer.

(2017) Cheryl L. Attard et al.   JOURNAL OF CLINICAL ONCOLOGY

Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

(2016) Davendra P.S. Sohal et al.   JOURNAL OF CLINICAL ONCOLOGY

Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer

(2016) Daniel A. Goldstein et al.   MEDICAL ONCOLOGY

Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study

(2015) Emily Nash Smyth et al.   CLINICAL THERAPEUTICS

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

(2015) D. Goldstein et al.   JNCI-Journal of the National Cancer Institute

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

(2015) D. Goldstein et al.   JNCI-Journal of the National Cancer Institute

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

(2014) L. Rahib et al.   CANCER RESEARCH

Historical Controls for Metastatic Pancreatic Cancer: Benchmarks for Planning and Analyzing Single-Arm Phase II Trials

(2014) P. A. Philip et al.   CLINICAL CANCER RESEARCH

Investigation of Adverse-Event-Related Costs for Patients With Metastatic Breast Cancer in a Real-World Setting

(2014) S. Hurvitz et al.   ONCOLOGIST

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

(2013) Daniel D. Von Hoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2012) T. Seufferlein et al.   ANNALS OF ONCOLOGY

Progression-Free Survival: Meaningful or Simply Measurable?

(2012) Christopher M. Booth et al.   JOURNAL OF CLINICAL ONCOLOGY

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE